phospho-RUNX1 (Ser249) Polyclonal Antibody, AbBy Fluor-488 Conjugated, BF488, Rabbit
Artikelnummer:
BSS-BS-3023R-BF488
- Bilder (0)
| Artikelname: | phospho-RUNX1 (Ser249) Polyclonal Antibody, AbBy Fluor-488 Conjugated, BF488, Rabbit |
| Artikelnummer: | BSS-BS-3023R-BF488 |
| Hersteller Artikelnummer: | bs-3023R-BF488 |
| Alternativnummer: | BSS-BS-3023R-BF488-100 |
| Hersteller: | Bioss |
| Wirt: | Rabbit |
| Kategorie: | Antikörper |
| Applikation: | IF, WB |
| Spezies Reaktivität: | Human, Mouse, Rat |
| Konjugation: | BF488 |
| Alternative Synonym: | RUNX1 Ser249, p-RUNX1 Ser249, RUNX1 phospho S249, RUNX1 phospho Ser249, Acute myeloid leukemia 1, Acute myeloid leukemia 1 protein, alpha subunit core binding factor, AML 1, AML1 EVI 1, AML1, Aml1 oncogene, AMLCR 1, AMLCR1, CBFA 2, CBFA2, Core binding factor alpha 2 subunit, Core binding factor runt domain alpha subunit 2, EVI 1, EVI1, HGNC, Oncogene AML 1, PEA2 alpha, PEBP2 alpha B, PEBP2A2, PEBP2aB, Polyomavirus enhancer binding protein 2 alpha B subunit, Run1, Runt related transcription factor 1, RUNX 1, SL3 3 enhancer factor 1 alpha B subunit, SL3/AKV core binding factor alpha B subunit, RUNX1_HUMAN. |
| AML1/Runx1 binds DNA as a monomer and through the Runt domain. DNA binding is increased by heterodimerization with CBFB. Isoform AML1L can neither bind DNA nor heterodimerize and interferes with the transactivation activity of AML1/Runx1. CBF binds to the core site, 5-PYGPYGGT-3, of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T cell receptor enhancers, LCK, IL3 and GMCSF promoters. The alpha subunit binds DNA and appears to have a role in the development of normal hematopoiesis. AML1/Runx1 is expressed in a wide variety of tissues and is expressed at the highest levels in thymus, bone marrow and peripheral blood. Defects in AML1/Runx1 are the cause of familial platelet disorder with associated myeloid malignancy, an autosomal dominant disease characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukemia. |
| Klonalität: | Polyclonal |
| Konzentration: | 1ug/ul |
| Puffer: | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Quelle: | KLH conjugated synthetic phosphopeptide derived from human RUNX1 around the phosphorylation site of Ser249 [QP(p-S)PP] |
| Target-Kategorie: | phospho-RUNX1 (Ser249) |
| Application Verdünnung: | WB(1:300-5000), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200) |
